CausalSentinel

Protein Dossier — JAG1 (Protein jagged-1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Large vessel disease -0.573 0.157 2.60e-04 Wald ratio 1 trans NA
Ulcerative colitis -0.159 0.0594 0.00735 Wald ratio 1 trans NA
Fractured bone site(s): Arm 0.234 0.0885 0.00825 Wald ratio 1 trans NA
Height 0.0328 0.0136 0.0164 Wald ratio 1 trans NA
Heel bone mineral density (BMD) T-score automated -0.0335 0.0143 0.0189 Wald ratio 1 trans NA
Diagnoses - main ICD10: B37 Candidiasis 0.671 0.298 0.024 Wald ratio 1 trans NA
Cardioembolic stroke 0.307 0.147 0.0369 Wald ratio 1 trans NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine -0.197 0.0954 0.0391 Wald ratio 1 trans NA
Packed cell volume -0.164 0.0801 0.0408 Wald ratio 1 trans NA
Alzheimer’s disease -0.142 0.071 0.0448 Wald ratio 1 trans NA
Parkinson’s disease -0.365 0.189 0.0532 Wald ratio 1 trans NA
Non-cancer illness code self-reported: muscle or soft tissue injuries 0.203 0.108 0.06 Wald ratio 1 trans NA
…and 107 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5092_51_3 JAG1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

125 association rows across 82 traits (120 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Estimated bone mineral density 1e-89 rs141094380 3 GCST90726625 no MR -> candidate analysis
Heel bone mineral density 1e-87 rs17457340 15 GCST006433 MR: beta=-0.0335, p=0.0189 (trans)
PSPN protein levels 1e-34 rs549768142 1 GCST90470364 no MR -> candidate analysis
CALCA protein levels 5e-26 rs3790163 1 GCST90468528 no MR -> candidate analysis
Brain morphology (MOSTest) 4e-25 rs6077868 2 GCST90239729 no MR -> candidate analysis
High light scatter reticulocyte count (UKB data field 30300) 4e-25 rs1997814 1 GCST90468076 no MR -> candidate analysis
Circulating CALCA levels 4e-25 rs3790163 1 GCST90860308 no MR -> candidate analysis
High light scatter reticulocyte percentage (UKB data field 3 3e-23 rs1997814 1 GCST90468077 no MR -> candidate analysis
Immature reticulocyte fraction (UKB data field 30280) 6e-21 rs1997814 1 GCST90468079 no MR -> candidate analysis
Lumbar spine bone mineral density 3e-19 rs3790160 1 GCST001482 MR: beta=0.0342, p=0.393 (trans)
Subcortical volume (MOSTest) 3e-19 rs6133987 1 GCST010702 no MR -> candidate analysis
Diastolic blood pressure (UKB data field 4079) 3e-19 rs889509 1 GCST90468163 no MR -> candidate analysis
…and 70 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1880 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Alagille syndrome due to a JAG1 point mutation 0.945 established (curated) no MR -> candidate analysis
Alagille syndrome 0.791 established (curated) no MR -> candidate analysis
Tetralogy of Fallot 0.85 established (curated) no MR -> candidate analysis
Charcot-Marie-Tooth disease, axonal, Type 2HH 0.867 established (curated) no MR -> candidate analysis
deafness, congenital heart defects, and posterior embryotoxon 0.834 established (curated) no MR -> candidate analysis
Abnormality of the cardiovascular system 0.875 established (curated) no MR -> candidate analysis
hypertensive disorder 0.851 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.81 common-variant locus no MR -> candidate analysis
Increased blood pressure 0.789 common-variant locus no MR -> candidate analysis
cataract 0.754 common-variant locus MR: beta=0.137, p=0.217 (trans)
migraine disorder 0.762 common-variant locus no MR -> candidate analysis
hereditary disease 0.721 established (curated) no MR -> candidate analysis
essential hypertension 0.696 common-variant locus no MR -> candidate analysis
keloid 0.648 common-variant locus no MR -> candidate analysis
osteoporosis 0.638 common-variant locus MR: beta=0.0665, p=0.425 (trans)

Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Protein jagged-1)
gnomAD constraint pLI=1, LOEUF=0.219 — LoF-INTOLERANT
GWAS Catalog 109 unique SNPs / 223 rows
ClinVar 2760 records; 12 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance